Summary
The effects of intensive versus regular therapy on incidence and progress of microalbuminuria in type 2 diabetes were compared. During a follow-up of 3 years, 96 cases of diabetes mellitus were randomized to intensive and regular therapy groups. HbA1c goal was same in the two groups, but the goal of blood pressure (Bp) and lipid was more strict in the intensive therapy group than in the regular therapy group. There was statistically significant difference in the incidence and progression of vascular complications between the two groups. Logistic stepwise-regression analysis (odds ration, OR) showed that there was significant difference in the progression of nephropathy (OR 0.24, 95% CI 0.12–0.76), retinopathy (OR 0.38, 95% CI 0.16–0.88), peripheral neuropathy (OR 0.42, 95% CI 0.22–0.86) and autonomic neuropathy (OR 0.29, 95% CI 0.12–0.86) between the two groups (P<0.01). It was concluded that intensive blood glucose controlling could retard diabetic vascular complications. Intensive therapy of multiple factors interventions (controlling Bp, regulating blood lipid, improving microcirculation) could decrease various risk factors for diabetic vascular complications.
Similar content being viewed by others
References
Shichiri M, Kishikawa H, Ohkubo Yet al. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care, 2000, 23 (Suppl 2): B21
Levin S R, Coburn J W, Abraira Cet al. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Diabetes Care, 2000, 23:1478
Estacio R O, Jeffers B W, Gifford Net al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care, 2000, 23 (Suppl2): B54
United Kingdom Prospective Study (UKPDS) Group (1998). Intensive blood control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352(9131): 837
Timothy C F. Evolution of the joint national committee reports, 1988–1997. Evolution of the science of treating hypertension. Arch Intern Med, 1997, 157(21): 2401
Lam K S, Cheng I K, Janus E Det al. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia, 1995, 38:604.
Author information
Authors and Affiliations
Additional information
WU Hanni, female, born in 1956, Associate Professor
This project was supported by grants from Science and Research Founction of the Ministry of Health (No. 96-2-102) and Hubei Provincial Natural Sciences Foundation (No. 96J077).
Rights and permissions
About this article
Cite this article
Hanni, W., Shuling, Z. & Di, S. Effect of intensive therapy of multiple factors intervention on vascular complications in type 2 diabetes. Current Medical Science 23, 16–18 (2003). https://doi.org/10.1007/BF02829451
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02829451